According to the results of a Cancer Research UK-funded clinical trial, giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back.
The findings of a new study have revealed that group therapy relieves psychological distress, improves the quality of life and results in fewer readmissions for heart problems.
Named as 'Aashray', the temporary shelter established by the CRPF on the request of the All India Institute of Medical Sciences (AIIMS) will reach out to the common man at the Trauma center in providing requisite amenities and the healing touch.
According to a recent study published in Canadian Medical Association Journal, patients with chronic obstructive pulmonary disease (COPD) who undergo major surgery are more likely to die in the year following surgery and have greater healthcare expenses than equivalent patients without COPD.
New Delhi [India], January 17 (ANI/PNN): The South Korean Company Stand Up Therapeutics Co., Ltd. specializes in researching gene therapies for paralyzed spinal cord injury patients. With the introduction of their alliance, industry leaders in gene delivery technology Stand Up Therapeutics a
Bengaluru (Karnataka) [India], January 16 (ANI/NewsVoir): Fibe (formerly known as EarlySalary) one of India's leading consumer lending platform has entered into a strategic partnership with Narayana Health, India's leading multi-speciality healthcare provider to offer low-cost and no-cost me
Hospitals have strong cleanliness and sanitation measures in place to protect patients from microorganisms that rarely affect healthy people but can be deadly to vulnerable patients who are already hospitalised with serious illnesses.
According to the statement from Zydus, Febuxostat tablets are indicated to lower hyperuricemia (high uric acid in the blood) in patients with gout who have been treated with allopurinol that did not work well or cannot be treated with allopurinol.
According to Sun Pharma, Palbociclib is approved by the US Food and Drugs Administration (FDA), European Medicines Agency (EMA) and Central Drugs Standard Control Organisation (CDSCO) in combination with hormonal therapies for patients with hormone receptor-positive, human epidermal growth f